News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Miriam Maney, MS

Articles by Miriam Maney, MS

Should Mitigating Comorbidities Be Considered in Assessing Healthcare Plan Performance in Achieving Optimal Glycemic Control?

ByLeonard M. Pogach, MD, MBA,Anjali Tiwari, MS,Miriam Maney, MS,Mangala Rajan, MBA,Donald R. Miller, ScD,David Aron, MD

March 1st 2007

Latest Updated Articles

Should Mitigating Comorbidities Be Considered in Assessing Healthcare Plan Performance in Achieving Optimal Glycemic Control?
Published: March 1st 2007 | Updated:

Trending on AJMC

Government Shutdown Concluded but ACA Subsidies in Limbo

How Trump’s Trade Policy Could Raise Costs, Deepen Drug Shortages

Can a Coffee a Day Keep AFib Away?

How MS Treatment Strategies Are Evolving: Rebecca Spain, MD

Early Measles Vaccination Surges in Texas Infants Amid 2025 Outbreak

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.